Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 807,894 |
|
|||||
| News | (1) | ||||||
| Day High | 35.48 | Low High |
|||||
| Day Low | 33.63 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Agios Pharmaceuticals Inc | AGIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.04 | -0.12% | 34.54 | 17:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 34.90 | 33.63 | 35.48 | 34.54 | 34.58 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,490 | 807,894 | $ 34.58 | $ 27,937,247 | - | 19.795 - 35.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:30:08 | 1 | $ 35.13 | USD |
Agios Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.94B | 56.19M | - | 26.82M | -352.09M | -6.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Agios Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AGIO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 31.70 | 35.48 | 31.31 | 33.16 | 673,392 | 2.84 | 8.96% |
| 1 Month | 27.80 | 35.48 | 27.14 | 30.69 | 713,175 | 6.74 | 24.24% |
| 3 Months | 24.25 | 35.48 | 24.18 | 30.22 | 780,413 | 10.29 | 42.43% |
| 6 Months | 21.20 | 35.48 | 20.40 | 26.49 | 721,632 | 13.34 | 62.92% |
| 1 Year | 22.85 | 35.48 | 19.795 | 25.98 | 588,148 | 11.69 | 51.16% |
| 3 Years | 56.36 | 62.155 | 16.75 | 31.19 | 598,959 | -21.82 | -38.72% |
| 5 Years | 52.00 | 62.155 | 16.75 | 36.77 | 641,336 | -17.46 | -33.58% |
Agios Pharmaceuticals Description
| Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. |
